Doctors in China — Page 7

Wang Guanyu is Deputy Director of Hepatobiliary and Pancreatic Surgery at Sir Run Run Shaw Hospital. He treats liver cancer, pancreatic cancer, hilar cholangiocarcinoma, gallbladder cancer, biliary stones, and portal hypertension, including complex hepatobiliary operations with minimally invasive and laparoscopic techniques. His training includes Tongji Medical University (1993–1998) under major surgical mentors and a doctorate in medicine.

Lei Jun is a specialist at Hainan Chengmei Hospital, serving as Deputy Chief Physician at the Geriatric Multidisciplinary Diagnosis and Treatment Center. She focuses on Medical Oncology, combining chemotherapy and molecular targeted therapy with precision treatment guided by genetic testing. For international patients, her approach is built around whole-process management for cancers such as lung, breast, stomach, and colorectal cancer.

Shu Yue is a specialist at Hainan Chengmei Hospital and serves as Director of the Cardiac Rehabilitation Department and Associate Chief Physician. She focuses on cardiac rehabilitation and exercise-based therapy for cardiovascular diseases and critical illnesses. Her work covers hypertension, hyperglycemia, hyperlipidemia, cardiopulmonary endurance assessment, and post-operative ICU care training after heart surgery.

Chen Wen is a specialist at Hainan Chengmei Hospital and leads the Nephrology Department as Chief Physician and Director. He focuses on primary glomerular diseases (including IgA nephropathy and lupus nephritis) and complex nephrology cases requiring hemodialysis or peritoneal dialysis. His team supports patients with home peritoneal dialysis through step-by-step video guidance and safety-focused home visits.

Dai Wenxin is a specialist at Hainan Chengmei Hospital and works as Chief Physician in a multidisciplinary geriatric medicine center. He treats Alzheimer’s disease and geriatric conditions while coordinating care for respiratory, cardiovascular, and nervous system disorders. His practice also includes tumor genetic diagnosis and precision oncology, using approaches such as chemotherapy, targeted therapy, immunotherapy, and High-intensity focused ultrasound (HIFU).

Li Caiyang is a specialist at Hainan Cancer Hospital (Hainan Chengmei Hospital) focused on ultrasound diagnosis for breast and thyroid diseases. He is described as an “ultrasound sentinel” who accurately identifies suspicious lesions, including very small deep findings. His ultrasound expertise helped identify a 0.8 cm breast lesion and guide minimally invasive breast surgery with pathology confirmation.

Lin Rongyu is a specialist at Hainan Chengmei Hospital and works as Deputy Chief Physician in Nephrology. She manages chronic kidney disease and acute kidney injury prevention/treatment, with expertise in primary and secondary glomerular diseases. Her hands-on dialysis support includes peritoneal dialysis catheterization and establishing hemodialysis catheter access.

Liu Yuehong is a specialist at Hainan Chengmei Hospital, serving as Vice President and Chief Physician. She treats metabolic diseases, endocrine system disorders, and osteoporosis, with particular research focus on diabetic retinopathy genetics. Her background includes graduation from Harbin Medical University in Endocrinology and Metabolic Diseases.

Tu Ruisha is a specialist at Hainan Chengmei Hospital and serves as Chief Physician and Director of Minimally Invasive Surgery. With 20 years of surgical experience, he performs laparoscopic and endoscopic oncologic procedures for gastric, colorectal, and thyroid tumors. He also acts as Secretary-General of the Hainan Cancer Prevention and Treatment Association.

Yu Xin is an anesthesiologist at Sir Run Run Shaw Hospital, serving as Assistant to the Director of the Department of Anesthesiology. She focuses on challenging anesthesia for complex and critically ill patients, including geriatric, cardiac macrovascular, and transplantation anesthesia. Her approach includes thoracic and cervical sympathetic blockade and peripheral nerve blocks for pain management, and she is described as implementing laparoscopic air embolism management and early warning systems first in China.

Cai Hongxin is a Senior Consultant in Orthopedics at Sir Run Run Shaw Hospital. He specializes in joint surgery and sports medicine, providing minimally invasive treatment for joint diseases in the shoulder, knee, and hip, as well as joint replacement and reconstruction. His training includes an M.D. from Zhejiang University (2011), fellowship at Loma Linda University (2015), and an AAHKS International Exchange Scholarship in 2018 for study at NewYork-Presbyterian Hospital.

Cai Xiaoyan is a Senior Consultant in General Surgery at Sir Run Run Shaw Hospital. She specializes in individualized surgical treatment for inguinal, incisional, umbilical, lumbar, and parastomal hernias, and also treats abdominal wall tumors and diastasis of the rectus abdominis with abdominal wall reconstruction. After graduating in 2000 from Zhejiang University, she earned a doctoral degree in 2012 and completed further training in Germany and at Fudan University-affiliated hernia and abdominal wall center.

Cai Xiujun is the President of Sir Run Run Shaw Hospital. SRRSH press materials describe how, under hospital leadership, she presented SRRSH’s whole-process innovation management experience in anti-epidemic work to the World Health Organization (WHO). The WHO sharing included presentation at WHO headquarters and the Western Pacific Region.

Chen Pengfei is an orthopedics specialist at Sir Run Run Shaw Hospital with over 10 years of clinical experience in traumatic orthopedics. He focuses on minimally invasive treatment of traumatic fractures in limbs and pelvis, including complex fracture surgeries involving shoulder and elbow joints and hip and knee joints. He also supports post-traumatic conservative treatment and postoperative rehabilitation exercises.

Fan Shunwu is a professor at Sir Run Run Shaw Hospital with more than 40 years of medical experience. His work is linked to bone metastasis-related diagnosis and treatment, addressing challenges such as late detection on X-ray and CT. SRRSH article content describes a proposed early-stage tumor-cell killing strategy by targeting tumasteoclasts.